AIQ analysis finds Fullspan Health’s content appearing in up to 81% of AI citations for key condition questions, and as much as 3.6x more often than competitors across ChatGPT, Claude and Gemini

NEW YORK, Sept. 22, 2026 /PRNewswire/ — Fullspan Health™, a unified B2B healthcare platform from RVO Health, today launched AIQ, a proprietary AI measurement and media optimization solution that helps health brands understand, measure, and improve their visibility across AI-powered search experiences. AIQ is available across campaigns running throughout the Fullspan Health portfolio, including Healthline®, Healthgrades®, Medical News Today®, Psych Central®, and Bezzy®.

AIQ Measures How Pharma Brands Appear in AI Answers
About 1 in 3 adults (32%) are turning to AI for health information and advice^[1], and among AI users, 59% are searching for treatment options based on a diagnosis^[2]. As consumers increasingly use AI at these high-intent moments, marketers face a new challenge: understanding whether their brands are visible in AI answers and how that visibility contributes to accurate patient understanding and campaign performance.

AIQ tracks when and how a brand is referenced, cited and linked across Google AI Overviews, Claude, ChatGPT, Gemini, and Perplexity. The tool offers actionable insights for marketers to both improve their own brand.com citations, and how to leverage the reach of Fullspan Health properties to enhance brand visibility. AIQ helps marketers understand if AI sees their brand, and how Fullspan Health campaigns can influence that visibility over time. Once a campaign launches, AIQ can track changes over time, understand where investment had an impact, and identify additional opportunities to expand into more topics or queries to help improve the impact.

Recent third-party data further underscores Healthline’s authority in AI search. According to Ahrefs, Healthline ranks No. 7 among the most-cited of all websites in ChatGPT and No. 13 in Google AI Overviews, and in both Healthline is the No. 1 ranked health publisher for AI citations.

Fullspan Health’s AIQ builds on more than a decade of Healthline search performance and health content expertise. That experience has informed proprietary agentic experience optimization (AEO) pillars that Fullspan Health uses to strengthen the visibility and authority of its own content in AI search. The company is now bringing those same principles to its advertising partners, helping optimize campaigns for AI discovery while measuring when and where brand messaging is cited and linked across leading AI platforms.

Fullspan Health Content Shows Strong AI Citation Visibility Across Key Therapeutic Areas
According to AIQ analysis, Fullspan Health content appeared in roughly two-thirds of ChatGPT, Claude, and Gemini answers across the sample set of prompts tested for key categories. High-performing conditions for widespread health needs include the following citation shares:

• 81% of migraine
• 79% of HPV prevention
• 73% of hypothyroidism
• 71% of type 2 diabetes/obesity
• 70% of breast cancer (full HR+/HER2-m)
• 66% of arthritis

Significant Competitive Advantages and Rare Disease Excellence
Fullspan Health content appeared 3.6 times more often than competitors in cardiovascular citations, 2.4 times more often in HIV, and 2 times more often in type 2 diabetes/obesity.

Fullspan Health’s AI visibility also excels in less common conditions with hard-to-reach audiences such as cystic fibrosis, appearing in 85.4% of cystic fibrosis sample prompts tested  across ChatGPT, Claude and Gemini. A separate July 2026 analysis of oncology and rare disease consumer queries across ChatGPT, Claude and Gemini, found that Healthline and Medical News Today were cited 15.5 times more often than the next-closest health publisher.

The results reflect the depth and medical review of Fullspan Health content across Healthline, Medical News Today, Psych Central, and Bezzy.

“AI is rapidly becoming a new front door to health, reshaping how consumers discover information, evaluate options and decide what to do next. For marketers, that creates a new imperative of understanding whether their brands appear in AI-generated answers and how to grow their share of voice.,” said Christine Maguire, EVP and Chief Business Officer of Fullspan Health. “AIQ demonstrates the impact of working  with Fullspan Health by showing marketers how our content and AEO optimization strategies are helping their brands appear, get cited and earn links in AI-generated answers. From there, AIQ further identifies opportunities to improve AI performance and tailors programs and packages to achieve each brand’s unique AEO objectives.”

AIQ is available now across all Fullspan Health advertising products and can be applied to the company’s recently announced 2027 marketing solutions.

Methodology
Fullspan Health tested an average of 200 unique questions or prompts across key conditions and therapeutic areas during the time frame of July through September 2026. Category reach represents the percentage of unique questions for which at least one tested AI model cited a Fullspan Health property, including Google AI Overviews, Claude, ChatGPT, Gemini, and Perplexity. Each question is counted once, regardless of how many tested models cited Fullspan Health for that question. For example, an 85% Category Reach means a Fullspan Health brand was cited for 85% of the unique questions tested.

About Fullspan Health
Fullspan Health is a B2B healthcare platform that combines data-driven tools, medically-backed content, and marketing services to improve health outcomes. Backed by trusted brands including Healthline, Healthgrades, Medical News Today, and more, it helps partners engage consumers and healthcare providers across the entire health journey, from discovery to care.

‍About RVO Health
RVO Health’s mission is to build a better way to health and wellbeing through empathy and empowerment. We help millions of people seek health information, find a doctor, save money, and take action around their health & wellbeing through Healthline, Healthgrades, and more. We are making health easier to navigate, more accessible, and more affordable for everyone. To learn more about RVO Health visit rvohealth.com.

^[1] KFF: “KFF Tracking Poll on Health Information and Trust: Use of AI For Health Information and Advice” March 2026

^[2] RockHealth: “The tortoise and the hare of care: Health AI insights from Rock Health’s 2025 Consumer Adoption Survey” March 2026

View original content to download multimedia:https://www.prnewswire.com/news-releases/aiq-by-fullspan-health-gives-pharma-marketers-a-way-to-measure-and-improve-visibility-in-ai-search-302885613.html

SOURCE RVO Health, LLC